Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Antimicrob Agents Chemother. 2020 Dec 16;65(1). doi: 10.1128/AAC.01693-20.
The EUCAST EDef 9.3.2 procedure recommends visual readings of azole and amphotericin B MICs against spp. Visual determination of MICs may be challenging. In this work, we aim to obtain and compare visual and spectrophotometric MIC readings of azoles and amphotericin B against isolates. A total of 847 isolates ( [ = 828] and cryptic species [ = 19]) were tested against amphotericin B, itraconazole, voriconazole, posaconazole, and isavuconazole using the EUCAST EDef 9.3.2 procedure. Isolates were classified as susceptible or resistant/non-wild type according to the 2020 updated breakpoints. The area of technical uncertainty for the azoles was defined in the updated breakpoints. Visual and spectrophotometric (fungal growth reduction of >95% compared to the control, read at 540 nm) MICs were compared. Essential (±1 2-fold dilution) and categorical agreements were calculated. Overall, high essential (97.1%) and categorical (99.6%) agreements were found. We obtained 100% categorical agreements for amphotericin B, itraconazole, and posaconazole, and consequently, no errors were found. Categorical agreements were 98.7 and 99.3% for voriconazole and isavuconazole, respectively. Most of the misclassifications for voriconazole and isavuconazole were found to be associated with MIC results falling either in the area of technical uncertainty or within one 2-fold dilution above the breakpoint. The resistance rate was slightly lower when the MICs were obtained by spectrophotometric readings. However, all relevant mutants were correctly classified as resistant. Spectrophotometric determination of azole and amphotericin B MICs against isolates may be a convenient alternative to visual endpoint readings.
EUCAST EDef 9.3.2 程序建议使用视觉方法读取唑类和两性霉素 B 对 spp 的 MIC 值。然而,视觉 MIC 值的确定可能具有挑战性。在这项工作中,我们旨在获得并比较唑类和两性霉素 B 对 分离株的视觉和分光光度 MIC 值读数。使用 EUCAST EDef 9.3.2 程序,对总共 847 株 分离株([=828]和隐种[=19])进行了两性霉素 B、伊曲康唑、伏立康唑、泊沙康唑和伊沙康唑的检测。根据 2020 年更新的折点,将分离株分类为敏感或耐药/非野生型。在更新的折点中定义了唑类药物的技术不确定区。比较了视觉和分光光度(与对照相比,真菌生长减少>95%,在 540nm 处读取)MIC 值。计算了基本(±1 倍稀释)和分类一致性。总体而言,发现了高基本(97.1%)和分类(99.6%)一致性。我们获得了两性霉素 B、伊曲康唑和泊沙康唑 100%的分类一致性,因此没有发现错误。伏立康唑和伊沙康唑的分类一致性分别为 98.7%和 99.3%。伏立康唑和伊沙康唑的大多数错误分类与 MIC 结果落在技术不确定区或折点上方一个 2 倍稀释范围内有关。通过分光光度法获得 MIC 值时,耐药率略低。然而,所有相关的 突变体均被正确分类为耐药。对 分离株的唑类和两性霉素 B MIC 值进行分光光度测定可能是视觉终点读数的一种方便替代方法。